Citation: Y. Theoret et Eg. Seidman, CO-SCREENING FOR PRIMARY BILIARY-CIRRHOSIS AND CELIAC-DISEASE - 6-MERCAPTOPURINE METABOLISM IN CROHNS-DISEASE - REPLY, Gut, 43(2), 1998, pp. 301-301
Citation: Rl. Kenigsberg et al., CHOLINERGIC CELL EXPRESSION IN THE DEVELOPING RAT MEDIAL SEPTAL NUCLEUS IN-VITRO IS DIFFERENTIALLY CONTROLLED BY GABA(A) AND GABA(B) RECEPTORS, Brain research, 805(1-2), 1998, pp. 123-130
Citation: C. Cuffari et al., INTRAVENOUS 6-THIOGUANINE (6-TG) PREVENTS REACTIVATION OF TRINITROBENZENE SULFONIC-ACID (TNBS)-INDUCED COLITIS, Gastroenterology, 112(4), 1997, pp. 954-954
Authors:
KENIGSBERG RL
HONG YG
YAO H
LEMIEUX N
MICHAUD J
TAUTU C
THEORET Y
Citation: Rl. Kenigsberg et al., EFFECTS OF BASIC FIBROBLAST GROWTH-FACTOR ON THE DIFFERENTIATION, GROWTH, AND VIABILITY OF A NEW HUMAN MEDULLOBLASTOMA CELL-LINE (UM-MB1), The American journal of pathology, 151(3), 1997, pp. 867-881
Citation: C. Cuffari et al., 6-MERCAPTOPURINE (6-MP) METABOLITE LEVELS IN ADULT AND PEDIATRIC IBD - CORRELATION WITH DRUG EFFICACY, Gastroenterology, 110(4), 1996, pp. 890-890
Citation: C. Cuffari et al., PHARMACOKINETICS EXPLAIN THE LACK OF SHORT-TERM EFFICACY OF 6-MERCAPTOPURINE (6-MP) IN THE TNBS RAT COLITIS MODEL, Gastroenterology, 110(4), 1996, pp. 890-890
Citation: C. Cuffari et al., QUANTITATION OF B-THIOGUANINE IN PERIPHERAL-BLOOD LEUKOCYTE DNA IN CROHNS-DISEASE PATIENTS ON MAINTENANCE 6-MERCAPTOPURINE THERAPY, Canadian journal of physiology and pharmacology, 74(5), 1996, pp. 580-585
Citation: C. Cuffari et al., 6-MERCAPTOPURINE (6-MP) METABOLITE MEASUREMENT IN IBD PATIENTS NEUTROPHILS CORRELATES WITH DRUG EFFICACY, Gastroenterology, 108(4), 1995, pp. 803-803
Citation: C. Cuffari et al., MEASUREMENT OF ERYTHROCYTE 6-MERCAPTOPURINE (6MP) METABOLITES IN IBD PATIENTS - CORRELATION WITH EFFICACY AND TOXICITY, Gastroenterology, 106(4), 1994, pp. 10001021-10001021